Showing 1 - 13 results of 13 for search 'Yutaro ABE', query time: 0.04s
Refine Results
-
1
Experimental study on PM deposition behavior in an EGR cooler by Tomohiko FURUHATA, Yutaro ABE, Yoshio ZAMA, Masataka ARAI
Published 2014-12-01
Article -
2
Focally Spared Region in Diffuse Type of Liver Metastasis From Renal Cell Carcinoma by Tasuku Nakabori, Yutaro Abe, Keiichiro Honma, Kazuyoshi Ohkawa
Published 2022-01-01
Article -
3
Factors Affecting Therapeutic Effects in 17 Patients with Advanced Hepatocellular Carcinoma Who Were Treated with Sorafenib for More than 12 Months by Kazuhiro Katayama, Ryosuke Kiyota, Toshihiro Imai, Yutaro Abe, Tadatoshi Nawa, Hiroshi Wada, Kazuyoshi Ohkawa
Published 2018-11-01
Article -
4
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma by Tasuku Nakabori, Sena Higashi, Yutaro Abe, Kaori Mukai, Toshiki Ikawa, Koji Konishi, Noboru Maeda, Katsuyuki Nakanishi, Shinichiro Hasegawa, Hiroshi Wada, Kazuyoshi Ohkawa
Published 2024-03-01
Article -
5
Usefulness of on‐site cytology of liver tumor biopsy in specimen sampling for cancer genomic profiling test by Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Risa Yoshioka, Yuki Morimoto, Yuki Koyanagi, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa
Published 2023-04-01
Article -
6
A case of refractory tumor bleeding from an ampullary adenocarcinoma: Compression hemostasis with a self‐expandable metallic stent by Kazuma Daiku, Kenji Ikezawa, Shingo Maeda, Yutaro Abe, Yugo Kai, Ryoji Takada, Takuo Yamai, Nobuyasu Fukutake, Tasuku Nakabori, Hiroyuki Uehara, Kazuyoshi Ohkawa
Published 2022-04-01
Article -
7
Sensitivity of cytology in liver tumor biopsy and its significance in the prompt clinical diagnosis of non‐hepatocellular carcinoma by Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Azusa Shingetsu, Sanako Nishimura, Sayoko Tsuzaki, Ayumi Ryu, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa
Published 2023-06-01
Article -
8
Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection by Tasuku Nakabori, Yutaro Abe, Sena Higashi, Takeru Hirao, Yasuharu Kawamoto, Shingo Maeda, Kazuma Daiku, Makiko Urabe, Yugo Kai, Ryoji Takada, Takuo Yamai, Kenji Ikezawa, Hiroyuki Uehara, Kazuyoshi Ohkawa
Published 2022-05-01
Article -
9
Primary Pancreatic Mantle Cell Lymphoma Diagnosed via Endoscopic Ultrasound-Guided Fine-Needle Aspiration by Takuo Yamai, Kenji Ikezawa, Kazuma Daiku, Shingo Maeda, Yutaro Abe, Yugo kai, Ryoji Takada, Tasuku Nakabori, Nobuyasu Fukutake, Hiroyuki Uehara, Hiroaki Masaie, Kaori Ishida, Chiaki Kubo, Kazuyoshi Ohkawa
Published 2021-06-01
Article -
10
5-Fluorouracil/L-Leucovorin Plus Oxaliplatin (FOLFOX) Regimen as Salvage Chemotherapy for Patients with Unresectable Pancreatic Cancer Receiving Gemcitabine and Nab-Paclitaxel and... by Takuo Yamai, Kenji Ikezawa, Yasuharu Kawamoto, Takeru Hirao, Sena Higashi, Kazuma Daiku, Shingo Maeda, Yutaro Abe, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Kazuyoshi Ohkawa
Published 2022-04-01
Article -
11
Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study by Yukio Kadokawa, Satoko Inoue, Akitoshi Tatsumi, Mayako Uchida, Keiko Fujita, Mari Takagi, Takako Inoue, Shuichi Ohe, Yasutomo Nakai, Tomoyuki Otsuka, Yutaro Abe, Tasuku Nakabori, Taiki Isei, Toru Kumagai, Kazuo Nishimura, Kazuyoshi Ohkawa
Published 2023-02-01
Article -
12
The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer by Ryoji Takada, Kenji Ikezawa, Kazuma Daiku, Shingo Maeda, Yutaro Abe, Makiko Urabe, Yugo Kai, Takuo Yamai, Nobuyasu Fukutake, Tasuku Nakabori, Hiroyuki Uehara, Reiko Ashida, Hirofumi Akita, Hidenori Takahashi, Teruki Teshima, Kazuyoshi Ohkawa
Published 2021-09-01
Article -
13
Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S‐1 as second‐line chemotherapy in metastatic pancreatic cancer... by Kenji Ikezawa, Ryosuke Kiyota, Ryoji Takada, Kazuma Daiku, Shingo Maeda, Toshihiro Imai, Yutaro Abe, Yugo Kai, Takuo Yamai, Nobuyasu Fukutake, Tasuku Nakabori, Reiko Ashida, Hiroyuki Uehara, Takahiro Tabuchi, Kazuhiro Katayama, Kazuyoshi Ohkawa
Published 2021-06-01
Article